Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent

Biochem Biophys Res Commun. 2005 Sep 30;335(3):832-5. doi: 10.1016/j.bbrc.2005.07.149.

Abstract

Insulin stimulates caveolin-1 and eNOS phosphorylation. The sulfonylurea glimepiride mimics several insulin actions by mechanisms that are poorly understood. Glimepiride induces caveolin-1 phosphorylation and activates PI3K and Akt in rat adipocytes. In this paper, we investigated the effect of glimepiride on eNOS activation in human endothelial cells. We found that glimepiride induces caveolin-1 and eNOS phosphorylation. To better understand the role of caveolin-1 in glimepiride action, we downregulated caveolin-1 expression by specific siRNA transfection. Caveolin-1 silencing did not change eNOS and Akt phosphorylation induced by glimepiride. On the contrary, LY294002, a specific PI3K inhibitor, blocked eNOS serine 1177 phosphorylation. These findings suggest that glimepiride induces eNOS phosphorylation in endothelial cells through an Akt-dependent mechanism, not regulated by caveolin-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caveolin 1
  • Caveolins / metabolism*
  • Cells, Cultured
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / metabolism
  • Enzyme Activation
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type III
  • Protein Serine-Threonine Kinases / metabolism*
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-akt
  • Sulfonylurea Compounds / pharmacology*

Substances

  • CAV1 protein, human
  • Caveolin 1
  • Caveolins
  • Hypoglycemic Agents
  • Proto-Oncogene Proteins
  • Sulfonylurea Compounds
  • glimepiride
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt